---
title: "Where and How to Inject Testosterone Enanthate"
description: "This step-by-step guide covers testosterone enanthate self-injection, including site and needle choice, the aspiration debate, dosing, and monitoring."
url: https://healthrx.com/testosterone-enanthate/self-injection-technique
publisher: HealthRX.com
---


HealthRX.com

The label names deep gluteal injection, not self-injection steps

50 to 400 mg Labeled dose for male hypogonadism, given every 2 to 4 weeks Source: dailymed.nlm.nih.gov

[Print or save as PDF](https://healthrx.com/printables/testosterone-enanthate/self-injection-technique?print=1)

Key numbers

- 400 mg Monthly total above which extra doses are not required, per the label Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e89d6458-428c-4256-97a3-f1fa851293c1), as cited Nov 7, 2026
- 17% Share of IM injections in overweight/obese adults given within ACIP guidelines (study of 22 women) Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/24156877/), as cited Nov 7, 2026
- 4.0 percent Mean hematocrit rise vs placebo with IM testosterone enanthate or cypionate (29 trials, 3,393 men) Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/34445892/), as cited Nov 7, 2026
- 90% Men on the subcutaneous autoinjector with average testosterone in the normal range at week 12 (135 of 150) Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a3d204c-be26-49e0-8599-0ac12a272e81), as cited Nov 18, 2026

[See the public record for Testosterone enanthate](https://healthrx.com/data/testosterone-enanthate)

HealthRX.com quick answer. The generic testosterone enanthate intramuscular label says to inject slowly and deeply into the gluteal muscle, following usual intramuscular precautions and avoiding intravascular injection [1]. It does not give patient self-injection steps [1]. The label dose for male hypogonadism is 50 to 400 mg every 2 to 4 weeks [1]. The only labeled subcutaneous testosterone enanthate product is a weekly autoinjector given in the abdomen, with its own step-by-step instructions for use [6].

At a glance

- Route (vial) / Deep gluteal intramuscular injection, given slowly [1]
- Labeled dose (vial) / 50 to 400 mg every 2 to 4 weeks [1]
- Monthly maximum / Total doses above 400 mg per month are not required [1]
- Injection frequency / More often than every 2 weeks rarely indicated [1]
- Self-injection (vial) / Not described in the prescribing information [1]
- Route (autoinjector) / Subcutaneous, abdomen only, once weekly, starting at 75 mg [6]
- Autoinjector hold time / Keep it pressed down for a full 10 seconds [6]
- Monitoring / Testosterone, hematocrit and prostate cancer risk in the first year per Endocrine Society [2]

## Label direction for intramuscular enanthate injection

Testosterone enanthate in a vial is injected into muscle, not under the skin: the label directs a slow injection deep into the gluteal muscle, and its carton text reads "For Intramuscular Use ONLY" [1]. The label itself gives no patient self-injection steps, so the technique for drawing up and injecting at home comes from a prescriber's or pharmacist's training, backed by the injection research below [1].

Before treatment, the label says to confirm hypogonadism with morning serum testosterone measured on at least two separate days, both below the normal range [1]. For male hypogonadism, the suggested dose is 50 to 400 mg every 2 to 4 weeks. Total doses above 400 mg per month are not required because of the prolonged action of the preparation, and injections more often than every 2 weeks are rarely indicated [1].

The administration instruction is specific about route and speed: inject slowly, deep into the gluteal muscle, following usual intramuscular precautions such as avoiding intravascular injection [1]. The label's administration paragraph does not give a needle gauge, needle length, aspiration step or site rotation schedule [1].

### Vial injection and autoinjector compared

Two different products exist, and their instructions are not interchangeable.

|  | Vial for intramuscular use [1] | Autoinjector for subcutaneous use [6] |
| --- | --- | --- |
| Strength | 200 mg/mL, in a 5 mL multiple-dose vial | 50, 75 or 100 mg in 0.5 mL, single-dose device |
| Route | Deep gluteal muscle | Subcutaneous, abdomen only |
| Dosing | 50 to 400 mg every 2 to 4 weeks | Start 75 mg once weekly, adjust by 25 mg |
| Dose changes | Based on response and adverse effects | Based on trough testosterone after 6 weeks |
| Patient instructions | None in the label | Instructions for use, with training before the first injection |
| Storage | 20 to 25 degrees C | 20 to 25 degrees C, do not refrigerate or freeze |

## Testosterone enanthate dose to syringe volume at 200 mg/mL

Because the vial label lists a concentration of 200 mg per mL, the volume for any labeled dose is simple arithmetic: dose in mg divided by 200 [1].

| Dose | Volume at 200 mg/mL |
| --- | --- |
| 50 mg | 0.25 mL |
| 75 mg | 0.375 mL |
| 100 mg | 0.5 mL |
| 200 mg | 1 mL |
| 400 mg (highest single dose in the labeled range) | 2 mL |

The label gives the range, not a personal dose: the prescriber sets the amount and the interval from the response and the blood tests [1]. A volume that looks different from the prescribed number is a reason to stop and check with the pharmacist before injecting.

### What to check in the vial before drawing up

The label describes the solution as clear, colorless to pale yellow, and says to inspect parenteral products for particles and discoloration before use [1]. It also says that a wet needle or wet syringe may make the solution cloudy without affecting potency, and that warming and rotating the vial between the palms redissolves crystals that form at low temperatures [1]. Cloudiness or crystals that do not clear are a reason to ask the pharmacist, because the label gives no further instruction.

## Reaching the muscle

The labeled site is the gluteal muscle [1]. A general review of intramuscular injection notes that IM injection is not a benign procedure and that unsafe practices can cause significant morbidity; it presents a guideline for evidence-based technique to limit injury and discomfort [3]. A study of 22 adult women found that 17% of injections in overweight and obese patients were given within ACIP guidelines, and concluded that the needle length used is often too short in overweight and obese individuals [4]. These findings are about IM injections generally, not a tested testosterone enanthate self-injection protocol.

### Ventrogluteal and dorsogluteal sites for a testosterone enanthate shot

Two gluteal sites are used. The ventrogluteal site sits at the hip, in an inverted triangle formed by the iliac crest, the anterior superior iliac spine and the greater trochanter of the femur, over the gluteus medius and minimus. The dorsogluteal site is in the upper outer area of the gluteus maximus and medius [7]. A systematic review and meta-analysis of 17 studies with 1,429 participants found that the ventrogluteal site was linked to less pain, less bleeding and less hematoma than the dorsogluteal site [7]. The same review notes that the ventrogluteal site lies farther from the sciatic nerve [7]. An analysis of 92 Turkish Supreme Court cases of injection-related sciatic nerve injury found that gluteal injections accounted for 79% of cases, and notes that international guidelines recommend the ventrogluteal site [10]. The label names the gluteal muscle without choosing between the two sites [1]. A person injecting alone cannot easily see or reach the ventrogluteal site, which is one reason the label's gluteal instruction is usually paired with in-person teaching.

### Intramuscular needle length by body size for testosterone enanthate

Needle length decides whether the oil reaches muscle or stays in fat. The sources opened for this page give these figures for gluteal injections.

| Source | Finding |
| --- | --- |
| Meta-analysis of gluteal fat thickness [7] | In normal-weight and overweight men, a 21 gauge, 38 mm (1.5 inch) needle could reach muscle at both gluteal sites; in obese patients a 50 mm needle would be necessary; in overweight women a 38 mm needle does not ensure an intramuscular injection |
| MRI study of 350 adults [8] | Ventral gluteal fat thickness correlated with BMI (r = 0.82 in women, 0.81 in men); BMI 30 in women and 35 in men were the upper limits for a 3.75 cm (1.5 inch) needle |
| Same MRI study [8] | Expected failure rate of intramuscular delivery with a 3.75 cm needle: 71% in women with BMI over 30 and 60% in men with BMI over 35 |
| Observation study of 22 women [4] | 90% of injections were within ACIP guidelines in normal and underweight patients, 17% in overweight and obese patients |

These are studies of intramuscular injection generally, not of testosterone enanthate specifically, and the label does not name a needle length [1]. The practical point from the data is that a standard short needle is the weak link in heavier patients, so needle length is a question for the prescriber or pharmacist, not something to guess.

### Aspiration before injecting testosterone enanthate

The label says to avoid intravascular injection but does not tell the patient to pull back on the plunger [1]. A 2026 meta-analysis of randomized trials (6 studies, 693 participants) found that aspiration increased pain scores (SMD 0.83) and prolonged injection time by an average of 4.53 seconds, and that no serious complications were reported when aspiration was omitted [9]. The authors concluded that the findings support international guidelines discouraging routine aspiration, especially in pediatric and vaccine settings, and that technique should be individualized by patient and medication [9]. The trials in that analysis were not testosterone oil injections, so a prescriber's instruction on aspiration takes priority.

Questions worth asking

Choose the questions you want to keep Is the gluteal muscle the only site my prescriber considers for this injection? Can you show me how to draw up and give the dose slowly and deeply? Should I hold the needle in place after injecting, and for how long? Which needle length and gauge fit my body size for an intramuscular injection? How often should I have testosterone, hematocrit and blood pressure checked? Which symptoms of a blood clot or high blood pressure should prompt a call to you?

Nurse Scott on giving an intramuscular injection with little pain

Nurse Scott argues that intramuscular injections can be given with far less pain than most people expect, and he credits the result to technique. He recommends choosing the outer middle part of the thigh, cleaning the skin, and letting the alcohol dry first. His main advice is to stretch the skin before inserting the needle, to jab quickly like a dart, and to cough at the moment of insertion so the brain is distracted from the pinch. He presents these tips from his own years of giving shots, and he frames the method as especially useful for people who fear starting hormone injections. He also stresses that this technique is for intramuscular shots, not subcutaneous ones like insulin.

Who is speaking?

Nurse Scott. Nurse, as named on the channel and in the video [Background](https://www.youtube.com/watch?v=Pz49hyOla6s)

[Episode notes and full video](https://www.youtube.com/watch?v=Pz49hyOla6s)

## Subcutaneous testosterone enanthate with the Xyosted autoinjector

The label for the subcutaneous product says it is for injection in the abdominal region only and says to avoid intramuscular or intravascular injection [6]. The patient instructions in that label include these steps [6]:

1. Do not inject until trained by the prescriber on the proper way to use the device.
2. Wipe the injection site with an alcohol swab and let it dry.
3. Use only the left or right side of the abdomen, and stay at least 2 inches away from the navel. Avoid skin that is tender, bruised, red, scaly, hard, scarred, tattooed or has stretch marks.
4. Squeeze the site into a raised area and keep the device at a 90 degree angle to the skin.
5. Push down and hold. After the click, keep the device pressed down for a full 10 seconds.
6. Check that the viewing window has turned orange. If unsure whether the dose was delivered, do not inject another dose; contact the prescriber or pharmacist.
7. Slight bleeding at the site is normal. Do not put the cap back on the device.
8. Do not refrigerate or freeze the device.

The label dosing is a 75 mg weekly start, with trough testosterone measured 7 days after the most recent dose after 6 weeks of dosing and after 6 weeks following any dose change. The dose goes down by 25 mg if the trough is 650 ng/dL or higher and up by 25 mg if it is below 350 ng/dL [6]. In the 52-week open-label study behind the label, 135 of 150 men (90%) had a time-averaged [total testosterone](https://healthrx.com/labs-total-testosterone/what-it-measures) within the normal range of 300 to 1100 ng/dL at week 12, and none had a peak above 1500 ng/dL [6].

## Site reactions, clots and hematocrit during self-injection

The label lists inflammation and pain at the injection site as adverse reactions [1]. It also lists polycythemia and venous thromboembolism, and says to discontinue treatment if a venous thromboembolic event is suspected [1]. The label says testosterone can increase blood pressure, that blood pressure should be monitored periodically, and that testosterone products are not recommended in patients with uncontrolled hypertension [1].

In a network meta-analysis of 29 placebo-controlled trials and 3,393 men, intramuscular testosterone enanthate or cypionate raised mean hematocrit by 4.0 percent versus placebo [5]. The Endocrine Society recommends monitoring symptoms, serum testosterone, hematocrit, and prostate cancer risk during the first year [2].

### Injection-site reactions in the subcutaneous testosterone enanthate trials

In the one-year study of 150 men on the autoinjector, injection site bruising occurred in 6.7%, injection site hemorrhage in 3.3% and injection site erythema in 2.7% [6]. In the 6-month study of 133 men, injection site hemorrhage occurred in 6.0% and bruising in 3.8% [6]. In the same one-year study, hematocrit increase was reported in 14.0% and hypertension in 12.7% [6]. In 24-hour ambulatory monitoring, systolic and diastolic blood pressure rose by an average of 3.9 and 1.5 mm Hg from baseline to week 12, and the label advises checking hematocrit approximately every 3 months [6].

## Medicines and conditions that limit self-injection

The label says patients on oral anticoagulants need close monitoring when androgens are started or stopped [1]. In diabetic patients, androgens may lower blood glucose and insulin requirements [1]. With corticosteroids or [ACTH](https://healthrx.com/labs-acth/what-it-measures), the label warns of an enhanced tendency toward edema and says to use caution, especially in patients with hepatic or cardiac disease [1]. Oxyphenbutazone levels may rise [1]. The label contraindicates testosterone enanthate in men with breast cancer or known or suspected prostate cancer, in women who are or may become pregnant, and in anyone with hypersensitivity to a component [1].

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. According to the label, which route and speed does the administration instruction specify for testosterone enanthate?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Try the tool

Free testosterone calculator

Work out free and bioavailable testosterone from total testosterone, SHBG and albumin with the Vermeulen equation.

[Open the calculator](https://healthrx.com/tools/free-testosterone)

Printable question sheet

Testosterone enanthate self-injection questions for your prescriber

Use this sheet before a visit where you plan to discuss self-injecting testosterone enanthate. Fill in your prescription details, bring it with your questions, and record injection site reactions between visits.

[Open the fill-in sheet](https://healthrx.com/printables/testosterone-enanthate/self-injection-technique) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

Where does the label say to inject testosterone enanthate?

Deep into the gluteal muscle, slowly, with usual intramuscular precautions and avoidance of intravascular injection [1].

Does the label give self-injection steps?

No. Its administration paragraph covers deep gluteal intramuscular injection but does not give patient self-injection instructions, needle gauge, needle length, aspiration steps, or a site rotation schedule [1]. The separate subcutaneous autoinjector label does include patient instructions for use [6].

What dose does the label recommend?

50 to 400 mg every 2 to 4 weeks for male hypogonadism [1]. At the labeled concentration of 200 mg/mL, that is 0.25 mL to 2 mL per injection [1].

What injection-site reactions does the label list?

Inflammation and pain at the injection site are listed adverse reactions for the vial [1]. In the subcutaneous autoinjector trials, bruising and hemorrhage at the site were the most common [6].

What should be monitored during treatment?

The Endocrine Society recommends monitoring symptoms, serum testosterone, hematocrit, and prostate cancer risk in the first year [2]. The label says to monitor blood pressure periodically [1].

Can testosterone enanthate be injected into the thigh?

The site named in the vial label is the gluteal muscle [1]. The thigh is not named in the label, so the site is the prescriber's decision.

Can testosterone enanthate be injected subcutaneously?

The vial is labeled for intramuscular use only [1]. The labeled subcutaneous product is a weekly autoinjector given in the abdomen, at least 2 inches from the navel [6].

Should the plunger be pulled back before injecting?

The label does not instruct it [1]. A 2026 meta-analysis found aspiration increased pain and injection time and that no serious complications were reported without it [9].

What if the oil looks cloudy or has crystals?

The label says a wet needle or syringe can make the solution cloudy without affecting potency, and that warming and rotating the vial between the palms redissolves crystals formed at low temperature [1].

References

Show all 11 references Hide references

1. U.S. National Library of Medicine, DailyMed. Testosterone enanthate injection USP intramuscular, Hikma prescribing information. [Testosterone enanthate injection USP intramuscular, Hikma label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e89d6458-428c-4256-97a3-f1fa851293c1)
2. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. [Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline](https://pubmed.ncbi.nlm.nih.gov/29562364/). J Clin Endocrinol Metab. 2018;103(5):1715-1744.
3. Nicoll LH, Hesby A. [Intramuscular injection: an integrative research review and guideline for evidence-based practice](https://pubmed.ncbi.nlm.nih.gov/12173166/). Appl Nurs Res. 2002;15(3):149-62.
4. Palma S, Strohfus P. [Are IM injections IM in obese and overweight females? A study in injection technique](https://pubmed.ncbi.nlm.nih.gov/24156877/). Appl Nurs Res. 2013;26(4):e1-4.
5. Nackeeran S, Kohn T, Gonzalez D, White J, Ory J, Ramasamy R. [The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials](https://pubmed.ncbi.nlm.nih.gov/34445892/). J Urol. 2022;207(1):44-51.
6. U.S. National Library of Medicine, DailyMed. XYOSTED (testosterone enanthate) injection, for subcutaneous use, prescribing information and instructions for use. [XYOSTED (testosterone enanthate) injection label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a3d204c-be26-49e0-8599-0ac12a272e81)
7. Roldan-Chicano MT, Rodriguez-Tello J, Cebrian-Lopez R, Moore JR, Garcia-Lopez MM. [Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection](https://pubmed.ncbi.nlm.nih.gov/37452553/): a systematic review and meta-analysis. Nurs Open. 2023;10(9):5975-5988.
8. Holliday RM, Gupta V, Vibhute PG. Body mass index: a reliable predictor of subcutaneous fat thickness and needle length for ventral gluteal intramuscular injections. Am J Ther. 2019;26(1):e72-e78. [Body Mass Index: A Reliable Predictor of Subcutaneous Fat Thickness and Needle Length for Ventral Gluteal Intramuscular Injections](https://pubmed.ncbi.nlm.nih.gov/27574934/)
9. Yildiz Karaahmet A, Senturan L. [Aspiration in intramuscular injection: a meta-analysis of pain, duration, and clinical outcomes](https://pubmed.ncbi.nlm.nih.gov/41051060/). Contemp Nurse. 2026;62(3):354-371.
10. Issi ES, Incebacak F. [Injection-induced sciatic nerve injuries in Turkey](https://pubmed.ncbi.nlm.nih.gov/41063125/): a public health and patient safety analysis of Supreme Court decisions. BMC Med Ethics. 2025;26(1):130.
11. Nurse Scott. [Painless Self Injection - 1.4 M Views!](https://www.youtube.com/watch?v=Pz49hyOla6s). Accessed 2026-11-11.

Next in this cluster

Related reading

- [testosterone enanthate Testosterone Enanthate Missed-Dose Protocol](https://healthrx.com/testosterone-enanthate/missed-dose-protocol)
- [testosterone enanthate Testosterone enanthate too much](https://healthrx.com/testosterone-enanthate/overdose-management)
- [testosterone enanthate Testosterone enanthate how to safely stop](https://healthrx.com/testosterone-enanthate/discontinuation-protocol)
- [testosterone enanthate Testosterone enanthate history](https://healthrx.com/testosterone-enanthate/history-development)
- [testosterone enanthate Testosterone Enanthate in Special Populations](https://healthrx.com/testosterone-enanthate/special-populations)
- [testosterone enanthate Testosterone enanthate storage](https://healthrx.com/testosterone-enanthate/storage-stability)
- [testosterone enanthate Testosterone enanthate switching](https://healthrx.com/testosterone-enanthate/switching-protocols)
- [testosterone enanthate Testosterone Enanthate Travel & Timezone-Shift Protocols](https://healthrx.com/testosterone-enanthate/travel-protocols)
- [testosterone enanthate Does TRICARE cover testosterone enanthate](https://healthrx.com/testosterone-enanthate/tricare-coverage)
- [testosterone enanthate Does UnitedHealthcare cover testosterone enanthate](https://healthrx.com/testosterone-enanthate/unitedhealthcare-coverage)
- [testosterone enanthate Testosterone enanthate dosing young adult](https://healthrx.com/testosterone-enanthate/young-adult-dosing)
- [testosterone enanthate Testosterone enanthate monitoring](https://healthrx.com/testosterone-enanthate/young-adult-monitoring)
- [testosterone enanthate Testosterone enanthate year 1 outcomes](https://healthrx.com/reviews-testosterone-enanthate/year-1-outcomes)
- [cypionate vs enanthate Cypionate vs enanthate](https://healthrx.com/mens-trt/cypionate-vs-enanthate)

![testosterone enanthate self-injection: hands arranging sterile supplies on a clean bathroom counter](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/testosterone-enanthate/self-injection-technique.webp)

Setting out clean, organized supplies before an injection is the first step in the self-injection routine described here. Full testosterone enanthate self-injection guide and sources at [healthrx.com/testosterone-enanthate](https://healthrx.com/testosterone-enanthate).
